News

Which paclitaxel schedule works best for breast cancer?


 

AT THE ASCO ANNUAL MEETING 2013

CHICAGO – Dr. G. T. Budd, of the Cleveland Clinic, discusses the efficacy, side effects, and costs of giving paclitaxel weekly vs. every 2 weeks when treating breast cancer. Dr. Budd discussed trial results comparing the schedules in an interview at the annual meeting of the American Society of Clinical Oncology.

Recommended Reading

Direct access to unexpected genetic test results
MDedge Family Medicine
Lipid metabolism genes linked to breast cancer subtype
MDedge Family Medicine
Breast cancer: Cardiac risk increases with radiation dose to heart
MDedge Family Medicine
Mammography screening at 75 may have value
MDedge Family Medicine
USPSTF draft recommendations update chemoprevention for breast cancer
MDedge Family Medicine
Supreme Court ponders patenting of human genes
MDedge Family Medicine
Study suggests statin use decreases breast cancer mortality
MDedge Family Medicine
Online cancer community colaunched by ex-Google executive
MDedge Family Medicine
ASCO guidelines for fertility preservation affirm oocyte preservation
MDedge Family Medicine
10 years of tamoxifen halves risk of death from breast cancer
MDedge Family Medicine